Table 2: Clinical characteristics of EHT, EHT + T2DM, and control subjects.

ParameterEHT ()EHT + T2DM ()Control ()

AGE59.45 ± 10.3459.05 ± 11.1052.51 ± 9.41
SBP152.01 ± 23.10150.51 ± 20.00122.21 ± 11.24
DBP94.12 ± 10.0093.00 ± 9.3476.20 ± 9.00
BMI26.21 ± 6.0228.04 ± 4.2525.00 ± 4.00
FBS5.46 ± 1.117.89 ± 1.355.04 ± 0.50
TCH5.02 ± 1.104.53 ± 1.045.10 ± 1.31
LDL3.01 ± 1.103.00 ± 1.003.21 ± 1.10
HDL1.34 ± 0.341.21 ± 0.301.30 ± 0.52
TG1.50 ± 0.522.00 ± 0.531.23 ± 0.55

EHT refers to essential hypertensive patients, EHT + T2DM refers to essential hypertensive patients with Type 2 Diabetes Mellitus, and control refers to healthy subjects. value is obtained by the comparisons of means between EHT and control subjects as well as between EHT + T2DM and control subjects, in the same row significant. Value mean ± standard deviation. Nonsignificant .